pharmaceuticals

Granules India Limited Q3 FY23; PAT Jumped Up To 124 Crore

● Feb 8, 2023

Granules India Limited (NSE: GRANULES) reported Revenue from Operations for Q3 FY23 of ₹1,146.12 Crore up from ₹996.76 Crore year...

SUVEN PHARMACEUTICALS LTD (SUVEN) Q3 FY23 Earnings Concall Transcript

● Feb 7, 2023

SUVEN PHARMACEUTICALS LTD (NSE:SUVEN) Q3 FY23 Earnings Concall dated Feb. 07, 2023. Corporate Participants: Rishab Barar — Investor Relations Venkat Jasti — Managing Director...

Aarti Industries Ltd Q3 FY23 Earnings Conference Call Insights

● Feb 7, 2023

Key highlights from Aarti Industries Ltd (AARTIIND) Q3 FY23 Earnings Concall Management Update: [00:04:16] AARTIIND said demand for textile products...

Gujarat Themis Biosyn Limited (506879) Q3 FY23 Earnings Concall Transcript

● Feb 7, 2023

Gujarat Themis Biosyn Limited (NSE:506879) Q3 FY23 Earnings Concall dated Feb. 06, 2023. Corporate Participants: Sachin Patel — Director Rajneesh Anand — Consultant Analysts:...

Aarti Industries Ltd (AARTIIND) Q3 FY23 Earnings Concall Transcript

● Feb 6, 2023

Aarti Industries Ltd (NSE: AARTIIND) Q3 FY23 Earnings Concall dated Feb. 06, 2023 Corporate Participants: Nishid Solanki — Investor Relations Rajendra Gogri — Chairman...

Jubilant Pharmova Limited (JUBLPHARMA ) Q3 FY23 Earnings Concall Transcript

● Feb 6, 2023

Jubilant Pharmova Limited (NSE:JUBLPHARMA) Q3 FY23 Earnings Concall dated Feb. 03, 2023. Corporate Participants: Vineet Mayer — Investor Relations and Corporate Finance...

GMM Pfaudler Limited (GMMPFAUDLR) Q3 FY23 Earnings Concall Transcript

● Feb 6, 2023

GMM Pfaudler Limited (NSE:GMMPFAUDLR) Q3 FY23 Earnings Concall dated Feb. 03, 2023. Corporate Participants: Priyanka Daga — Deputy General Manager Tarak Patel — Managing...

Divis Labs Ltd.(NSE:DIVISLAB )|Q3 FY23 Results Out|Total Income rises 5% yoy

● Feb 3, 2023

Divi’s Laboratories Limited (NSE: DIVISLAB) is a pharmaceutical company specializing in the manufacture of active pharmaceutical ingredients (APIs) and intermediates....

Jubilant Pharmova Limited Q3 FY23; Revenue Increased By 18%

● Feb 3, 2023

Jubilant Pharmova Limited (NSE: JUBLPHARMA) reported a Revenue from Operations of ₹1,533.22 Crores, a boost of 18% growth from the...

Alembic Pharmaceuticals Limited (APLLTD) Q3 FY23 Earnings Concall Transcript

● Feb 2, 2023

Alembic Pharmaceuticals Limited (NSE:APLLTD) Q3 FY23 Earnings Concall dated Feb. 01, 2023. Corporate Participants: R.K. Baheti — Director, Finance and Chief Financial...